2nd Quarter - Report

NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$960,101
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Taxation of carried interest; capital gains tax policy; Energy tax extenders, Energy Innovation Tax

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; Securities & Exchange Commission (SEC); Office of the Vice President of the United States; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Telecommunications TEC

S 2105 Cybersecurity Act of 2012; HR 4263/S2151 - Secure IT Act of 2012; Bills to protect critical infrastructure against cyber based espionage and IP theft, and terror attacks; Privacy and information sharing issues.

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Treasury, Dept of; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 4263 (112th)

Health Issues HCR

S 1700 The Medical Device Regulatory Improvement Act - support and clarify FDA's least burdensome rules.

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; Office of the Vice President of the United States; SENATE; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office

Immigration IMM

Specific lobbying issue: Support for EB6 - The Start Up Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country. HR 3692 Invest Act. S 3217 Start Up Act - Allows STEM graduates to remain in the US HR 3012 HR 5893 - Increase the per family sponsored VISAS; eliminates the per country limit on VISAS.

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: White House Office; Securities & Exchange Commission (SEC); SENATE; Food & Drug Administration (FDA); Office of the Vice President of the United States; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3012 (112th), H.R. 5893 (112th), H.R. 3692 (112th)

Banking BAN

S 1933/HR 3606 The Reopening American Capital Markets to Emerging Growth Companies Act of 2011: Support the entire bill

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Securities & Exchange Commission (SEC); Office of the Vice President of the United States; SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 3606 (112th)

Copyright/Patent/Trademark CPT

HR 3261 Stop Online Piracy Act; S968 Protect IP Act; Oppose SOPA and PIPA - oppose the Private Right of Action and the DNS provisions in the bills.

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Treasury, Dept of; SENATE; Office of the Vice President of the United States

Bills named: H.R. 3261 (112th)

Energy/Nuclear ENG

Renewable energy policy issues: Loan guarantee program and clean energy deployment administration budget issues for FY2012. Continuing resolution: budget issues for FY2012 Energy and Water; ARPA-E Funding. Clean Energy Standard Act of 2012(CESA)

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; SENATE; Office of the Vice President of the United States

Medical/Disease Research/Clinical Labs MED

S.1734/HR2182 Gain Act - support incentives for antibiotic development; S2113 Treat Act; HR 4132 - FAST ACT - support expanding accelerated approval pathway

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Food & Drug Administration (FDA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Securities & Exchange Commission (SEC); Office of the Vice President of the United States

Bills named: H.R. 4132 (112th), H.R. 2182 (112th), S. 1734 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.